J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 66 (1985), 1641-1660; DOI 10.1099/0022-1317-66-8-1641
© 1985 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Hinuma, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Hinuma, Y.
Agricola
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Hinuma, Y.

Viral Aetiology of Adult T-Cell Leukaemia

Naoki Yamamoto1 and Yorio Hinuma2

1 Department of Virology and Parasitology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755
and2 Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606, Japan

Overall conclusions: Regarding the cause of leukaemias or malignant lymphomas, several advances in viral oncology and immunology have merged recently, resulting in a heightened appreciation of the associations between viral infection, immunodeficiency and genetic predisposition. In humans, EBV infection has been discussed thoroughly from these standpoints in relation to BL, X-linked lymphoproliferative syndrome, ataxia telangiectasia and malignant lymphomas after organ transplantations (Purtilo et al., 1984). In a previous section describing possible mechanisms of leukaemogenesis of ATL we discussed mainly transformation at the cellular level and not at the level of the host organism. It is apparent, however, that the fate of the transformed cell at the cellular level will be determined eventually by confrontation with the various immunological barriers of the host. Variation at the cellular level, of course, should be closely related to a changed response to the host immune mechanism. Cytogenetic alterations most probably endow transformed cells not only with a growth advantage at the cellular level but also with an ability to escape the immune surveillance of the host. The results described in this context clearly indicate that HTLV/ATLV is a prerequisite for the occurrence of ATL. It is also obvious, however, that this disease is ‘a chronic malignancy’ which requires a long period of time between viral infection and the occurrence of disease. This strongly indicates that some forces operate to select out a single cell and to initiate its monoclonal growth from the population of the cells which had been infected polyclonally with HTLV/ATLV. Although HTLV/ATLV is one of the major factors in the development of ATL, one or more additional factors seem to be necessary. Such factors can be assumed to be both exogenous and endogenous. It appears to us that ATL carcinogenesis results from the interaction of HTLV/ATLV with various biological, physical and chemical factors in the environment (Yamamoto, 1984).

Keywords: ATL, aetiology, human retrovirus




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Hieshima, D. Nagakubo, T. Nakayama, A.-K. Shirakawa, Z. Jin, and O. Yoshie
Tax-Inducible Production of CC Chemokine Ligand 22 by Human T Cell Leukemia Virus Type 1 (HTLV-1)-Infected T Cells Promotes Preferential Transmission of HTLV-1 to CCR4-Expressing CD4+ T Cells
J. Immunol., January 15, 2008; 180(2): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Yoshie, R. Fujisawa, T. Nakayama, H. Harasawa, H. Tago, D. Izawa, K. Hieshima, Y. Tatsumi, K. Matsushima, H. Hasegawa, et al.
Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
Blood, March 1, 2002; 99(5): 1505 - 1511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1985 by the Society for General Microbiology.